Changes are coming to our lives and world that may rival the industrial and internet revolutions. Jeremy Schwartz and Kara Marciscano discuss the BioRevolution already underway and identify the range of business sectors we believe are best positioned to benefit.
Mapping the road ahead for any market environment is already hard enough, but it’s even more difficult this time as we finally exit the pandemic. No matter your economic forecast for the near future, Brian Manby explains why the WisdomTree U.S. SmallCap Fund (EES) can be a part of it.
When investors think of foreign small-cap equities, they often intuitively expect discounted valuations relative to U.S. large caps, to compensate for higher volatility. Jeremy Schwartz and Matt Wagner explain why Japanese small caps may deserve consideration by value-starved asset allocators.
Positioning your portfolio toward small-cap strategies could lead to the inclusion of speculative “meme stocks.” Jeff Weniger analyzes the possible risks of these stocks on your portfolio and how to potentially avoid them.
The bond sell-off earlier this year has led to high levels of interest rate sensitivity in the stock market. Jeff Weniger makes the case for equity investors to allocate toward value stocks in a rising interest rate environment.
There is potential for interest rates to rise in reaction to or in anticipation of a red-hot Q2 GDP report. Jeff Weniger outlines small-cap strategies to potentially get ahead of it.
We believe there is a unique opportunity today to ride the economic recovery in Europe that has yet to find its footing. Brian Manby explains why investors seeking to access European economic recovery should consider our Europe SmallCap Dividend Fund (DFE).